drugset
drugset / Trial / NCT00121433

Leptin and Endothelial Function

NCT00121433 ↗

Phase 4 Completed 15 enrolled University of Michigan Amgen · collab
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this trial was to determine if injections of leptin would improve vascular function in normal-weight, healthy volunteers.

Timeline

Start
2004-09
Primary completion
—
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Leptin Protein / enzyme biologic 0.2 mg/kg Subcutaneous

Indications

No indication recorded.